NPI: 1396969499 · OMAHA, NE 68131 · General Acute Care Hospital · NPI assigned 04/12/2007
Authorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
| Authorized Official | KUIPER, EVERT (CEO - CHI HEALTH) |
| NPI Enumeration Date | 04/12/2007 |
Other providers sharing the same authorized official: KUIPER, EVERT
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 78 | $0.00 |
| 2022 | 891 | $21K |
| 2023 | 448 | $6K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 291 | 264 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 269 | 242 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 291 | 264 | $5K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 15 | 13 | $992.30 |
| 81025 | 13 | 13 | $44.34 | |
| J3490 | Unclassified drugs | 156 | 42 | $0.00 |
| 81001 | 15 | 13 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 367 | 75 | $0.00 |